TRADING_as_a_BUSINESS

IKT Technical Analysis πŸ§™

Pembelian
NASDAQ:IKT   Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Diseases and related disorders inside and outside the brain. Its pipeline product, IkT-148009, targets underlying disease mechanisms to reverse the course of Parkinson's disease and the GI complications of Parkinson's disease.

If you understand the idea,🎯 press a thumb up! πŸ‘ Have a question? Don't be shy to ask! πŸ€“ Interested to study how to analyze charts, follow me!
Trading ditutup: target tercapai:
closed the trade with the profit

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.